pyridostigmine bromide has been researched along with tacrine in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (6.67) | 18.7374 |
| 1990's | 5 (33.33) | 18.2507 |
| 2000's | 1 (6.67) | 29.6817 |
| 2010's | 7 (46.67) | 24.3611 |
| 2020's | 1 (6.67) | 2.80 |
| Authors | Studies |
|---|---|
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Galli, A; Mori, F | 1 |
| Fischer, JP; Kewitz, H; Thomsen, T; Zendeh, B | 1 |
| Arnal, F; Coté, LJ; Ginsburg, S; Lawrence, GD; Naini, A; Sano, M | 1 |
| Kewitz, H; Pleul, O; Thomsen, T | 1 |
| Glick, D; Loewenstein-Lichtenstein, Y; Nørgaard-Pedersen, B; Schwarz, M; Soreq, H; Zakut, H | 1 |
| Ariel, N; Barak, D; Bino, T; Ordentlich, A; Shafferman, A; Velan, B | 1 |
| Bajgar, J | 1 |
| Hasan, MY; Kuča, K; Lorke, DE; Nurulain, SM; Petroianu, GA; Shafiullah, M | 2 |
| Kassa, J; Korabecny, J; Sepsova, V; Tumova, M | 1 |
| Hasan, MY; Kuča, K; Lorke, DE; Nurulain, SM; Petroianu, GA | 2 |
15 other study(ies) available for pyridostigmine bromide and tacrine
| Article | Year |
|---|---|
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Effectiveness of 1,2,3,4-tetrahydro-9-aminoacridine (THA) as a pretreatment drug for protection of mice from acute diisopropylfluorophosphate (DFP) intoxication.
Topics: Animals; Brain; Cholinesterase Inhibitors; Diaphragm; Dose-Response Relationship, Drug; Isoflurophate; Male; Mice; Physostigmine; Poisoning; Pyridostigmine Bromide; Tacrine; Time Factors | 1991 |
In vitro effects of various cholinesterase inhibitors on acetyl- and butyrylcholinesterase of healthy volunteers.
Topics: Acetylcholinesterase; Butyrylcholinesterase; Cholinesterase Inhibitors; Erythrocytes; Humans; Physostigmine; Pyridostigmine Bromide; Tacrine; Tetraisopropylpyrophosphamide | 1991 |
Studies on new, centrally active and reversible acetylcholinesterase inhibitors.
Topics: Acetylcholinesterase; Animals; Blood-Brain Barrier; Brain; Cholinesterase Inhibitors; Dopamine; Male; Mice; Neostigmine; Norepinephrine; Pyridostigmine Bromide; Tacrine | 1990 |
Estimation of cholinesterase activity (EC 3.1.1.7; 3.1.1.8) in undiluted plasma and erythrocytes as a tool for measuring in vivo effects of reversible inhibitors.
Topics: Acetylcholinesterase; Butyrylcholinesterase; Carbon Radioisotopes; Cholinesterase Inhibitors; Cholinesterases; Erythrocytes; Female; Humans; Kinetics; Male; Physostigmine; Pyridostigmine Bromide; Radioisotope Dilution Technique; Reference Values; Sex Factors; Tacrine | 1988 |
Genetic predisposition to adverse consequences of anti-cholinesterases in 'atypical' BCHE carriers.
Topics: Acetylcholinesterase; Binding Sites; Butyrylcholinesterase; Butyrylthiocholine; Carbamates; Cholinesterase Inhibitors; Homozygote; Humans; Male; Pyridostigmine Bromide; Tacrine | 1995 |
The 'aromatic patch' of three proximal residues in the human acetylcholinesterase active centre allows for versatile interaction modes with inhibitors.
Topics: Acetylcholinesterase; Alkaloids; Binding Sites; Cholinesterase Inhibitors; Crystallography, X-Ray; Humans; Hydrogen Bonding; Kinetics; Ligands; Models, Chemical; Models, Molecular; Physostigmine; Protein Conformation; Pyridostigmine Bromide; Sesquiterpenes; Structure-Activity Relationship; Tacrine | 1998 |
Protective effect of reversible cholinesterase inhibitors (tacrine, pyridostigmine) and eqbuche against VX poisoning and brain acetylcholinesterase inhibition in rats.
Topics: Animals; Brain; Chemical Warfare Agents; Cholinesterase Inhibitors; Female; Neurotoxicity Syndromes; Organothiophosphorus Compounds; Pyridostigmine Bromide; Rats; Rats, Wistar; Tacrine | 2008 |
Pretreatment for acute exposure to diisopropylfluorophosphate: in vivo efficacy of various acetylcholinesterase inhibitors.
Topics: Amiloride; Animals; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Erythrocytes; Female; Humans; Inhibitory Concentration 50; Isoflurophate; Male; Methylene Blue; Metoclopramide; Oximes; Physostigmine; Proportional Hazards Models; Pyridinium Compounds; Pyridostigmine Bromide; Ranitidine; Rats; Tacrine; Tiapride Hydrochloride | 2011 |
Usefulness of administration of non-organophosphate cholinesterase inhibitors before acute exposure to organophosphates: assessment using paraoxon.
Topics: Animals; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Lethal Dose 50; Male; Organophosphate Poisoning; Oximes; Paraoxon; Physostigmine; Pyridostigmine Bromide; Ranitidine; Rats; Rats, Wistar; Tacrine; Tiapride Hydrochloride | 2013 |
The evaluation of prophylactic efficacy of newly developed reversible inhibitors of acetylcholinesterase in soman-poisoned mice - a comparison with commonly used pyridostigmine.
Topics: Animals; Antidotes; Cholinesterase Inhibitors; Lethal Dose 50; Male; Mice; Piperazines; Pyridostigmine Bromide; Soman; Tacrine | 2014 |
Reversible cholinesterase inhibitors as pre-treatment for exposure to organophosphates: assessment using azinphos-methyl.
Topics: Animals; Azinphosmethyl; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Male; Oximes; Physostigmine; Proportional Hazards Models; Pyridinium Compounds; Pyridostigmine Bromide; Ranitidine; Rats; Rats, Wistar; Tacrine | 2015 |
Combined Pre- and Posttreatment of Paraoxon Exposure.
Topics: Animals; Cholinesterase Inhibitors; Cholinesterase Reactivators; Male; Organophosphates; Oximes; Paraoxon; Physostigmine; Post-Exposure Prophylaxis; Pre-Exposure Prophylaxis; Proportional Hazards Models; Pyridostigmine Bromide; Ranitidine; Rats; Rats, Wistar; Survival Analysis; Tacrine | 2020 |